About GalvusMet
GalvusMet is a fixed dose combination drugs consists of Vildagliptin/Metformin. I t is indicated in the treatment of type 2 diabetes mellitus, for adult patients who are unable to achieve...
GalvusMet® (vildagliptin/metformin)
SEE APPROVED PRODUCT INFORMATION BEFORE PRESCRIBING. About GalvusMet Galvus®Met is a ............ See moreAbout Asthma
Asthma is a common chronic disease that imposes a significant burden on patients, their families and the community. 1 The World Health Organization (WHO) estimated about 383,000 asthma related deaths in 2015. 2
In...
Role of IgE
IgE is a key mediator of allergic reactions and plays a central role in both chronic airway inflammation and acute asthma-related symptoms 1 .
Targeting IgE has an impact on various downstream elements of inflammation, including...
About COPD
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disorder characterized by persistent and progressive airfow obstruction, affecting 6–10% of adults worldwide[1]. In the Asia–Pacific region, the prevalence of COPD was estimated as...
Asthma
Sandostatin® (octreotide)
(Octreotide) Oncology OncologyWhen to use JAKAVI (ruxolitinib)
When to use JAKAVI (ruxolitinib)Use JAKAVI as soon as patients are eligible to bring the most benefit to their lives 1-4 ...
Prescribing JAKAVI (ruxolitinib) for MF
Prescribing JAKAVI (ruxolitinib) for MFJAKAVI is recommended for patients with MF with symptomatic splenomegaly and/or MF-...
Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic ReactionsWell-characterized and manageable...
×
Ask Speakers
×